Denosumab treatment of skeletal related events from denosumab side effects Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Prof Allan Lipton speaks about three studies comparing the use of denosumab with traditional bisphosphonate based therapy for cancer patients with bone metastases. Denosumab is an antibody which targets a molecule which stimulates oesteoblasts. Patients treated with this drug experienced a lower number of skeletal related events, reduction in pain levels and increased quality of life. Prof Lipton compares the level of side effects in patients treated with denosumab with those of patients treated
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)